These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10854439)

  • 1. Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity.
    Hoare SR; Clark JA; Usdin TB
    J Biol Chem; 2000 Sep; 275(35):27274-83. PubMed ID: 10854439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR; Usdin TB
    Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH
    Weaver RE; Mobarec JC; Wigglesworth MJ; Reynolds CA; Donnelly D
    Biochem Pharmacol; 2017 Mar; 127():71-81. PubMed ID: 28012961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
    Hoare SR; Usdin TB
    J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
    Goold CP; Usdin TB; Hoare SR
    J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels.
    Eichinger A; Fiaschi-Taesch N; Massfelder T; Fritsch S; Barthelmebs M; Helwig JJ
    Endocrinology; 2002 Aug; 143(8):3036-43. PubMed ID: 12130570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rat parathyroid hormone 2 receptor antagonist.
    Kuo J; Usdin TB
    Peptides; 2007 Apr; 28(4):887-92. PubMed ID: 17207559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues.
    Hoare SR; Rubin DA; Jüppner H; Usdin TB
    Endocrinology; 2000 Sep; 141(9):3080-6. PubMed ID: 10965877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of tuberoinfundibular peptide of 39 residues.
    Piserchio A; Usdin T; Mierke DF
    J Biol Chem; 2000 Sep; 275(35):27284-90. PubMed ID: 10856302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The parathyroid hormone 2 (PTH2) receptor.
    Usdin TB; Bonner TI; Hoare SR
    Recept Channels; 2002; 8(3-4):211-8. PubMed ID: 12529938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist.
    Jonsson KB; John MR; Gensure RC; Gardella TJ; Jüppner H
    Endocrinology; 2001 Feb; 142(2):704-9. PubMed ID: 11159842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple regions of ligand discrimination revealed by analysis of chimeric parathyroid hormone 2 (PTH2) and PTH/PTH-related peptide (PTHrP) receptors.
    Clark JA; Bonner TI; Kim AS; Usdin TB
    Mol Endocrinol; 1998 Feb; 12(2):193-206. PubMed ID: 9482662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family.
    Hansen IA; Jakob O; Wortmann S; Arzberger T; Allolio B; Blind E
    J Endocrinol; 2002 Jul; 174(1):95-102. PubMed ID: 12098667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging functions for tuberoinfundibular peptide of 39 residues.
    Usdin TB; Dobolyi A; Ueda H; Palkovits M
    Trends Endocrinol Metab; 2003 Jan; 14(1):14-9. PubMed ID: 12475607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues.
    Usdin TB; Wang T; Hoare SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 2000 Oct; 21(4):349-83. PubMed ID: 11013069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1).
    Smock SL; Vogt GA; Castleberry TA; Lu B; Owen TA
    Mol Biol Rep; 2001; 28(4):235-43. PubMed ID: 12153143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation.
    Misiano P; Scott BB; Scheideler MA; Garnier M
    Eur J Pharmacol; 2003 May; 468(3):159-66. PubMed ID: 12754053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and stability of a new PTH1 receptor antagonist, mouse TIP(7-39).
    Hoare SR; Usdin TB
    Peptides; 2002 May; 23(5):989-98. PubMed ID: 12084532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
    Turner PR; Mefford S; Bambino T; Nissenson RA
    J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.